Crohn's Disease
Crohn's disease is a type of inflammatory bowel disease (IBD) that causes inflammation of the digestive tract, leading to symptoms such as abdominal pain, severe diarrhea, fatigue, weight loss, and malnutrition.
Guselkumab for Crohn's Disease Healing
We are studying whether guselkumab can help heal the intestinal wall in patients with Crohn's disease. This research aims to find out how effective it is over 48 weeks.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Do you have Crohn's disease that has lasted at least 3 months?
- Is your Crohn's disease currently active with a stool frequency of 4 or more per day?
- Have you had any bowel surgery in the last 6 months?
- Are you currently taking any advanced therapies for Crohn's disease like infliximab, adalimumab, or ustekinumab?
- Do you have any complications from Crohn's disease that might require surgery?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Az Maria Middelares Gent
BE10003:Gastro-enterologie
Gent, Belgium
Universitair Ziekenhuis Gent
BE10001:Gastroenterology
Ledeberg, Belgium
Vitaz
BE10002:Gastro-enterologie
Sint-Niklaas, Belgium
Sponsor: Janssen - Cilag International
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.